Postpartum Etonogestrel Implant for Adolescents (PPImplant)
Etonogestrel-releasing Subdermal Implant for Adolescents in the Postpartum Period: a Randomized Controlled Trial
Sponsor: University of North Carolina, Chapel Hill
A PHASE4 clinical study on Adolescence and Contraception, this trial is completed. The trial is conducted by University of North Carolina, Chapel Hill and has accumulated 9 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 4 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jun 2017 — Jun 2018 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Feb 2017 — Jun 2017 [monthly]
Unknown Status PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status PHASE4
First recorded
Aug 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of North Carolina, Chapel Hill
For direct contact, visit the study record on ClinicalTrials.gov .